173 Avsnitt

  1. Ep135: John Maraganore on Developing a New Class of Medicines

    Publicerades: 2023-05-08

  2. Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies

    Publicerades: 2023-04-24

  3. Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies

    Publicerades: 2023-04-12

  4. Ep132: Eric Dobmeier on Treating Kidney Disease

    Publicerades: 2023-03-28

  5. Ep131: Ryan Watts on Neuroscience Drug R&D

    Publicerades: 2023-03-14

  6. Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave

    Publicerades: 2023-02-28

  7. Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

    Publicerades: 2023-02-14

  8. Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last

    Publicerades: 2023-02-01

  9. Ep127: Jeb Keiper on Computational Drug Discovery

    Publicerades: 2023-01-20

  10. Ep126: DA Wallach on Becoming a Biotech VC

    Publicerades: 2023-01-03

  11. Ep125: Barry Greene on a New Drug for Depression

    Publicerades: 2022-12-19

  12. Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines

    Publicerades: 2022-11-08

  13. Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

    Publicerades: 2022-10-27

  14. Ep122: Aetna Wun Trombley on Extracellular Protein Degraders

    Publicerades: 2022-10-11

  15. Ep121: Samantha Truex on Going Upstream Against Severe Asthma

    Publicerades: 2022-09-26

  16. Ep120: Tim Lu on Gene Circuits for Cell Therapy

    Publicerades: 2022-09-07

  17. Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease

    Publicerades: 2022-08-22

  18. Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes

    Publicerades: 2022-08-08

  19. Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World

    Publicerades: 2022-07-11

  20. Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience

    Publicerades: 2022-06-22

3 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site